#mesothelioma Tech News.
1 story in the last 7 days
The latest mesothelioma news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks mesothelioma across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AIFinancial Timesabout 2 hours ago
Insilico Gets FDA Fast Track for ISM6331Insilico Medicine received FDA Fast Track designation for ISM6331, an AI-driven pan-TEAD inhibitor, for treating advanced mesothelioma. The designation aims to expedite development and regulatory review of the drug candidate.
Summaries by ByteBrief